Sanofi upgraded to hold by Deutsche Bank
Deutsche Bank has upgraded Sanofi (NASDAQ:SNY) to hold from sell, citing the company's Q4 earnings report. The investment ...
Sanofi upgraded to Hold at Deutsche Bank after ‘solid’ Q4 report
Deutsche Bank upgraded Sanofi (SNY) to Hold from Sell with a price target of EUR 100, up from EUR 85, following the company’s “solid” Q4 ...
Investing9d
Deutsche Bank maintains Celanese stock Buy rating ahead of Q4 results
Tuesday, Deutsche Bank (ETR:DBKGn) analysts maintained a Buy rating on shares of Celanese Corporation (NYSE:CE) with a steady price target of $85.00. The firm anticipates the forthcoming Q4 ...
Deutsche Bank: Bullish, But No Longer All-In
Deutsche Bank reported solid Q4 results with €7.2 billion in revenue, driven by a 30% YoY jump in the investment bank. Read more about DB stock here.
Deutsche Bank’s Heavier Costs Drag Shares Despite Investment Bank Strength
The lender’s better-than-expected performance in investment banking was overshadowed by a drop in profit and shares slumped ...